Most Attractive Stocks: Green Mountain Coffee, JPMorgan, Valeant, AT&T, Transocean, and Allstate

PRLog (Press Release) - May 4, 2012 - Green Mountain Coffee Roasters Inc. (NASDAQ:GMCR): Green Mountain Coffee Roasters Inc. (NASDAQ:GMCR) lately reported net sales for second quarter fiscal year 2012 were increased by 37% to US$885.1 million, from net sales of US$647.7 million in the prior-year quarter. For the same quarter, GAAP net income was about US$93.0 million, compared with US$65.4 million a year ago. Abnormal trading volume of Green Mountain Coffee was found on May 3 reaching 87.19 million shares, 16 times heavier than usual day trading. The stock sharply fell 47.76% to US$25.87. Share prices of Green Mountain Coffee have traded as high as US$115.98 per share and as low as US$24.40 in the past 52 weeks. Are insiders starting to take huge profits by selling shares or exercising stock options? Academic studies have shown that insiders traditionally make higher investment returns than ordinary investors. Want to find out how they do it?

Read Full Report: http://www.insiderslab.com/PR3/050412A/GMCR/GreenMountain...

JPMorgan Chase & Co. (NYSE:JPM): By the end of Thursday’s trading, JPMorgan Chase & Co. (NYSE:JPM) dropped US$0.19 per share (equivalent to 0.44%), where stock prices fell to US$43.01. In the past 52 weeks, JPMorgan share prices have been bracketed by a low of US$27.85 and a high of US$46.49, and are now at US$43.01, 54% above that low price. The move occurred on volume of 19.49 million which is relative to 30.14 million shares traded on average each day. The company has a market capitalization of 164.38 billion. Investors may want to find out how company insiders like Executive Officers and Directors are thinking about the future business prospects of the company. Check this insider trade report for JPM here.

Read Full Report: http://www.insiderslab.com/PR3/050412A/JPM/JPMorgan.pdf

Valeant Pharmaceuticals International, Inc. (NYSE:VRX): Valeant Pharmaceuticals International, Inc. (NYSE:VRX) announced on Thursday that the company has decided to buy certain assets from University Medical Pharmaceuticals Corp., a specialty pharmaceutical company focused on skincare products, in exchange of approximately US$64 million plus potential milestones based upon attainment of future revenue targets. By market close, Valeant plunged 9.23% to US$51.24. Abnormal trading volume of Valeant was found reaching 13.70 million shares, 13 times heavier than usual day trading. Why? Did insiders like CEOs, CFOs, and Directors sell their shareholdings before the stock price dropped? Check out the insider trade report here.

Read Full Report: http://www.insiderslab.com/PR3/050412A/VRX/Valeant.pdf

Today Insiderslab.com also observed abnormal trade volume for the following companies; insiders may involve trading in these companies. It will take some time for insiders to report their trades. Read these reports and add these companies into your Insider Trade Radar.

AT&T Inc. (NYSE:T):
Read Full Report: http://www.insiderslab.com/PR3/050412A/T/ATT.pdf

Transocean LTD (NYSE:RIG):
Read Full Report: http://www.insiderslab.com/PR3/050412A/RIG/Transocean.pdf

The Allstate Corporation (NYSE:ALL):
Read Full Report: http://www.insiderslab.com/PR3/050412A/ALL/Allstate.pdf

Insider Filing Source Reference: All observations, analysis and reports are based on public information released by the U.S. Securities and Exchange Commission.

About Insiderslab.com:

Insiderslab.com covers insider trade data in major stock markets in the U.S., Hong Kong, Mainland China, and Singapore.  Insiderslab.com features a team of experienced data analysts striving to provide the investment community with the tools, software, and data necessary to carry out more effective investment research.

Important Disclaimer:
Please visit insiderslab.com/disclaimers/disclaimers.php for details.

CONTACT: Insiders.hk, Insiderslab.com, info@insiderslab.com, Support@insiders.hk
SOURCE Insiderslab.com; Insiders.hk
Editor: Janet Nan Jiang